Rep. Castor Introduces the Advancing Safe Medications for Moms and Babies Act to Study Drug Safety
This bill is currently in the early stages of the legislative process after being sent to the House Committee on Energy and Commerce. It is actively moving forward as it awaits review by committee members. There are no upcoming votes scheduled at this time.
The bill has support from both parties and addresses a major gap in medical knowledge, but most bills face a long road through committees before becoming law.
This bill directly targets pregnant and lactating women by requiring that FDA regulations be updated to include them in clinical research, launching an education campaign so they can find and enroll in studies, and prioritizing NIH research on drugs they commonly use. Over time, this could lead to much better safety information about medications taken during pregnancy and breastfeeding, filling a major gap in medical knowledge that currently forces doctors to prescribe drugs without solid evidence of their effects on mothers and babies.
Referred to the House Committee on Energy and Commerce.
Introduced in House
The bill was officially filed and given a number. It now enters the legislative queue.
No votes have been recorded for this legislation yet.
No related news coverage found for this legislation yet.
Document Type
Congressional Bill
Official Title
Advancing Safe Medications for Moms and Babies Act of 2026
Analysis generated by AI. Always verify with official sources.